Glycoproteins

DBCAT000083Pharmacologic class

Conjugated protein-carbohydrate compounds including mucins, mucoid, and amyloid glycoproteins. A DrugBank category of 50 drugs. 23 of them are approved.

Also known as: Glycoprotein · Neoglycoproteins
Drugs: Adecatumumab
Alefacept
Alpha-1-proteinase inhibitor
Anatumomab mafenatox
Atacicept
Avidin
Balugrastim
Conestat alfa
Darbepoetin alfa
Drotrecogin alfa
EDI-200
Efbemalenograstim alfa
Eflapegrastim
Epoetin beta
Epoetin delta
Erythropoietin
Fibronectin
Filgrastim
Gastric intrinsic factor
GI-6207
Hemopexin
Human C1-esterase inhibitor
Lactoferrin
Lenograstim
Leridistim
and 25 more with a free account

What you can answer from here — as of August 24, 2016

50DrugsEach linked to its full drug card

57Drug targetsEvery drug–target pair in the class, with bond type

2,819Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Glycoproteins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account